These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33251553)

  • 1. Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye - evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN
    Bodaghi B; Nguyen QD; Jaffe G; Khoramnia R; Pavesio C
    J Ophthalmic Inflamm Infect; 2020 Nov; 10(1):32. PubMed ID: 33251553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluocinolone acetonide ophthalmic--Bausch & Lomb: fluocinolone acetonide Envision TD implant.
    Drugs R D; 2005; 6(2):116-9. PubMed ID: 15777105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral 0.19 mg Fluocinolone Acetonide Intravitreal Implant in the Successful Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Secondary Macular Oedema: A Case Report and Review of Intravitreal Therapies.
    Ansari AS; Amir Z; Williams GS
    Ophthalmol Ther; 2021 Mar; 10(1):193-200. PubMed ID: 33464558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months.
    Moll-Udina A; Hernanz I; Sainz-de-la-Maza M; Pelegrín L; Coelho-Borges AI; Pazos M; Adán A; Llorenç V
    Int Ophthalmol; 2023 Nov; 43(11):4181-4195. PubMed ID: 37698661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluocinolone acetonide intravitreal implant (Iluvien®): in diabetic macular oedema.
    Sanford M
    Drugs; 2013 Feb; 73(2):187-93. PubMed ID: 23335133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India.
    Biswas J; Tyagi M; Agarwal M;
    Ophthalmol Sci; 2024; 4(1):100403. PubMed ID: 38027419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye.
    Mikhail M; Sallam A
    Med Hypothesis Discov Innov Ophthalmol; 2013; 2(4):113-20. PubMed ID: 24822232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema.
    Weber LF; Marx S; Auffarth GU; Scheuerle AF; Tandogan T; Mayer C; Khoramnia R
    J Ophthalmic Inflamm Infect; 2019 Jan; 9(1):3. PubMed ID: 30694420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Pouwels XGLV; Petersohn S; Carrera VH; Denniston AK; Chalker A; Raatz H; Armstrong N; Shah D; Witlox W; Worthy G; Noake C; Riemsma R; Kleijnen J; Joore MA
    Pharmacoeconomics; 2020 May; 38(5):431-441. PubMed ID: 31701471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
    ; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA
    JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-infectious uveitis affecting the posterior segment treated with fluocinolone acetonide intravitreal implant: 3-year fellow eye analysis.
    Pavesio C; Heinz C
    Eye (Lond); 2022 Jun; 36(6):1231-1237. PubMed ID: 34117380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal Fluocinolone Acetonide Implant (ILUVIEN
    Mushtaq Y; Mushtaq MM; Gatzioufas Z; Ripa M; Motta L; Panos GD
    Drug Des Devel Ther; 2023; 17():961-975. PubMed ID: 37020801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of the 0.19 mg fluocinolone acetonide implant in treating non-infectious posterior uveitis: a real-world experience.
    Kozak I; Gurbaxani A; Pandova M
    J Ophthalmic Inflamm Infect; 2024 Jun; 14(1):24. PubMed ID: 38833091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment.
    Steeples LR; Pockar S; Jones NP; Leal I
    Clin Ophthalmol; 2021; 15():1433-1442. PubMed ID: 33854297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN
    Syed YY
    Drugs; 2017 Apr; 77(5):575-583. PubMed ID: 28283896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sjögren's syndrome-related keratopathy: a case report.
    Wasielica-Poslednik J; Pfeiffer N; Gericke A
    J Med Case Rep; 2019 Jan; 13(1):21. PubMed ID: 30674351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients.
    Studsgaard A; Clemmensen KØ; Nielsen MS
    Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1633-1639. PubMed ID: 34851465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Approach for Diabetic Macular Edema Treatment: review of clinical practice results with 0.19 mg fluocinolone acetonide intravitreal implant including vitrectomized eyes.
    Estebainha R; Goldhardt R; Falcão M
    Curr Ophthalmol Rep; 2020 Mar; 8(1):1-10. PubMed ID: 32346496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained Control from Recurring Non-Infectious Uveitic Macular Edema with 0.19 mg Fluocinolone Acetonide Intravitreal Implant - A Case Report.
    Meira J; Madeira C; Falcão-Reis F; Figueira L
    Ophthalmol Ther; 2019 Dec; 8(4):635-641. PubMed ID: 31506865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.